Maspin, a 42 kDa protein produced in normal breast cells, has been shown to inhibit the invasion and metastasis of breast cancer in an animal model. Ingestion of acetylsalicylic acid (aspirin) by breast cancer patients has been reported to restore the systemic synthesis of maspin through the stimulation of systemic nitric oxide production. Studies were carried out to determine the effect of aspirin on the incidence of breast cancer metastasis, which is reported to occur in 50% of patients who have previously received chemotherapy, radiation, and ⁄ or surgery. Thirty-five female patients (aged 41-65 years) with breast cancer who had previously received these therapies took one 75 mg ⁄ 70 kg body weight enteric-coated aspirin tablet every 24 h, after an adequate meal, for 3 years. Their plasma nitric oxide and maspin levels were measured. The occurrence of metastasis was ascertained monthly by a qualified oncologist, and confirmed, if necessary, by biopsy. Daily ingestion of aspirin by participants resulted in an increase in maspin levels from 0.95 ± 0.04 to 4.63 ± 0.05 nM after 24 h. These levels were maintained for 3 years. These studies suggest that daily ingestion of aspirin might significantly reduce the incidence of breast cancer metastasis in patients who have previously received anticancer therapies. (Cancer Sci 2010; 101: 2105-2109 M ammary serpin (maspin), a serine proteinase inhibitor, has been reported to prevent ⁄ control breast cancer.( 1) This protein (42 kDa) is reported to be synthesized abundantly in normal mammary epithelial cells through the expression of maspin mRNA.(2,3) However, the synthesis of the protein is reported to progressively decrease with the progression of breast cancer.(2,3) Exogenously administered maspin in an animal model has been shown to reduce the growth and metastasis of breast cancer as well as to block tumor motility and invasion, (4,5) and the effect of maspin was reported to be reversed by the use of antimaspin antibody.(6) Considering the anticancer properties of maspin, it is possible to suggest that the protein plays a critically important role in the prevention of metastasis as well as in the development of breast cancer.It has been reported that the synthesis of this protein under physiological conditions is regulated by insulin-induced nitric oxide (NO) synthesis, and the impaired maspin synthesis in breast cancer (2,3) was related to the impairment of insulinreceptor interaction in the malignant cells, leading to impaired NO synthesis.(7) Maspin production in human breast cancer can be restored to normal ranges by using aspirin, which stimulates NO synthesis independently of the insulin receptor both in the case of malignant breast cancer cells in vitro, and in breast cancer patients who ingest the compound orally.(8) This effect of aspirin, resulting in the stimulation of NO synthesis in various cells, has been reported to be independent of the well-known effect of aspirin on the inhibition of prostaglandin synthesis. (9) Breast cancer is well known for its pr...